Arı Hatem, Kahraman Fatih, Acaban Murat Baver
Department of Cardiology, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Turk Kardiyol Dern Ars. 2015 Apr;43(3):284-7. doi: 10.5543/tkda.2015.45735.
Hyponatremia is frequently seen in heart failure patients and has a high mortality rate. If not treated adequately, acute and chronic hyponatremia may worsen the prognosis of heart failure. Despite its high incidence in heart failure patients, other underlying conditions that possibly lead to the incidence of hyponatremia may be underestimated, thus making its treatment more difficult. In this case study, we describe a rare case of levetiracem-induced and tolvaptan-resistant hyponatremia.
低钠血症在心力衰竭患者中很常见，且死亡率很高。如果治疗不充分，急性和慢性低钠血症可能会使心力衰竭的预后恶化。尽管低钠血症在心力衰竭患者中的发病率很高，但其他可能导致低钠血症发生的潜在疾病可能被低估，从而使其治疗更加困难。在本病例研究中，我们描述了一例罕见的左乙拉西坦诱导且对托伐普坦耐药的低钠血症病例。
